Rencher William F. 4
4 · Context Therapeutics Inc. · Filed Feb 17, 2022
Insider Transaction Report
Form 4
Rencher William F.
Head of CMC and Regulatory
Transactions
- Award
Stock Option (right to buy)
2022-02-15+8,000→ 8,000 totalExercise: $2.05Exp: 2032-02-14→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal installments with 1/10th vesting on the date of this grant and each grant thereafter occurring on the last day of each calendar month until fully vested on October 31, 2022.